6934 Share Price Performance
NT$83.10
28.20 (51.37%)
Price NT$83.10
Share Pricen/a
No recently updated narratives available.
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.